LEAH CLARKE: Open Payments
NPI 1669640827 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 64 payments from 14 companies in 2025. Trend: 2023 $1,389 · 2024 $1,646 · 2025 $1,292
Food & beverage: $1,182Education: $110
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 22 | $242 |
| ABBVIE INC. | 13 | $240 |
| PFIZER INC. | 7 | $174 |
| Janssen Biotech, Inc. | 4 | $155 |
| Arcutis Biotherapeutics, Inc. | 2 | $120 |
| Lilly USA, LLC | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| GENZYME CORPORATION | 1 | $31 |
Products named: OPZELURA, SKYRIZI, CIBINQO, TREMFYA, Zoryve, DUPIXENT, TALTZ, Sotyktu.
Industry payments across CA — which companies pay providers there.
